You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 144 No. 3, March 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Study
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Pain
 •Dermatologic Disorders, Other
 •Genetics
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Primary Erythermalgia as a Sodium Channelopathy

Screening for SCN9A Mutations: Exclusion of a Causal Role of SCN10A and SCN11A

Joost P. H. Drenth, MD, PhD; Rene H. M. te Morsche, MS; Sahar Mansour, BMBS, FRCP; Peter S. Mortimer, MD, FRCP

Arch Dermatol. 2008;144(3):320-324.

Objectives  To elucidate the rate of missense mutations in the SCN9A gene (which encodes sodium channel Nav1.7) (OMIM 603415) among patients with primary erythermalgia and to examine the possibility that other sodium channels can cause the disease.

Design  Case series.

Setting  Department of Medicine, Radboud University Nijmegen, the Netherlands.

Participants  Six patients with sporadic and 9 with unique familial primary erythermalgia.

Interventions  Questionnaire to determine clinical profile and sequencing of all coding exons from SCN9A and those of SCN10A (OMIM 604427) and SCN11A (OMIM 604385) in 2 selected cases with a clear family history of the disease.

Main Outcome Measures  Detection of SCN9A mutation.

Results  We identified 1 patient with an SCN9A mutation. This mutation (I848T) has been associated with primary erythermalgia. Sequencing of 2 other candidate genes did not show mutations in 2 patients with familial primary erythermalgia.

Conclusions  The Nav1.7 voltage-gated sodium channels are related to syndromes of altered nociception. We detected a low SCN9A mutation rate in patients with primary erythermalgia, suggesting that pain syndromes in the skin may have a polygenic basis.


Author Affiliations: Division of Gastroenterology and Hepatology, Department of Medicine, University Medical Center St Radboud, Nijmegen, the Netherlands (Dr Drenth and Mr te Morsche); and South West Thames Regional Genetics Service (Dr Mansour), and Cardiac and Vascular Sciences, St George's Hospital Medical School (Dr Mortimer), London, England.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Dermatology in the Postgenomic Era: Harnessing Human Variation for Personalized Medicine
Anthony E. Oro
Arch Dermatol. 2008;144(3):389-391.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sensory symptoms and the skin
Burge and Wallis
Oxford Handbook of Medical Dermatology 2010;1:med-9780199558322-div1-02-med-9780199558322-div1-02.
FULL TEXT  

Dermatology in the Postgenomic Era: Harnessing Human Variation for Personalized Medicine
Oro
Arch Dermatol 2008;144:389-391.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.